Skip to content

Trial · Interventional

Status unknownPhase 4Registry data

Timing of HCG Administration in IUI Cycles

NCTNCT02330705 (opens ClinicalTrials.gov in a new tab)Other idMIE3
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Status unknown
Phase
Phase 4
Enrollment
225 participants (estimated)
Sponsor
Mohamed Ibrahem Eid · Other
Design
Randomized · Open label (no masking)
Countries
1 country

Egypt

Start
Jan 2015
Primary completion
Jul 2019 (estimated)
Completion
Aug 2019 (estimated)
First posted
5 Jan 2015 (estimated)
Last update posted
25 Jan 2019
Conditions
Infertility

Timeline

1 trial

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
201520162017201820192020
  1. Ph 4

    Timing of HCG Administration in IUI Cycles

    NCT02330705

    Jan 2015 to est. Aug 2019

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.

Interventions

  • HCGDrug

Arms3

  • Active comparator

    Group A

    IUI at time of HCG

  • Active comparator

    Group B

    IUI 12 hours after HCG

  • Active comparator

    Group C

    IUI 34-36 hours after HCG

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Clinical pregnancy rate

    Time frame · 4-6 weeks after IUI

    Registry description

    Number of clinical pregnancies (defined as presence of at least one intrauterine gestational sac with fetal pole and cardiac activity on TVS scan at 4-6 weeks after IUI) divided by the number of IUI cycles

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

A trial that is still running, or that stopped early, may post results later.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex
Female
Age
from 20 Years up to 35 Years
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * Mild male factor infertility or unexplained infertility. Exclusion Criteria: * Advanced male factor infertility. * Polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria. * Endometriosis. * Tubal disease. * Uterine abnormalities or myoma. * Previous uterine surgery. * Metabolic or hormonal abnormalities.

PepBank is a research reference. Talk to a doctor before you use any peptide.